IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEBORAH P MECCA VALENTE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1073549218
CMS profile
11215335
Location
AMHERST, NY

General Payments · PY2021–2024

$2,839.83

  • Reported across 119 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,113.61

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,101.46 50
Education $12.15 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Vanda Pharmaceuticals Inc. $224.00 5
ABBVIE INC. $182.80 10
ITI, Inc. $149.60 10
Otsuka America Pharmaceutical, Inc. $138.17 7
Neurocrine BioSciences, Inc. $90.32 4
Lundbeck LLC $88.86 4
Alkermes, Inc. $80.29 3
Takeda Pharmaceuticals U.S.A., Inc. $51.47 3
Axsome Therapeutics, Inc. $37.51 2
Corium, Inc. $32.86 1
Indivior Inc. $24.55 1
Teva Pharmaceuticals USA, Inc. $13.18 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $209.99 7
PY2022 $391.81 17
PY2023 $1,124.42 44
PY2024 $1,113.61 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.36 01/01/2024 Food and Beverage Undisputed 01/23/2026 1107644372 CMS
ABBVIE INC. $19.73 01/23/2024 Food and Beverage Undisputed 01/23/2026 1107644374 CMS
ABBVIE INC. $11.25 01/25/2024 Food and Beverage Undisputed 01/23/2026 1107644376 CMS
ABBVIE INC. $16.95 02/27/2024 Food and Beverage Undisputed 01/23/2026 1107644378 CMS
ABBVIE INC. $28.33 04/30/2024 Food and Beverage Undisputed 01/23/2026 1107644380 CMS
ABBVIE INC. $17.84 06/11/2024 Food and Beverage Undisputed 01/23/2026 1107644382 CMS
ABBVIE INC. $12.38 07/23/2024 Food and Beverage Undisputed 01/23/2026 1107644384 CMS
ABBVIE INC. $23.70 07/26/2024 Food and Beverage Undisputed 01/23/2026 1107644386 CMS
ABBVIE INC. $17.71 09/11/2024 Food and Beverage Undisputed 01/23/2026 1107644388 CMS
ABBVIE INC. $20.55 11/19/2024 Food and Beverage Undisputed 01/23/2026 1107644390 CMS
Alkermes, Inc. $24.73 05/16/2024 Food and Beverage Undisputed 01/23/2026 1120552784 CMS
Alkermes, Inc. $26.79 09/06/2024 Food and Beverage Undisputed 01/23/2026 1120552786 CMS
Alkermes, Inc. $28.77 11/05/2024 Food and Beverage Undisputed 01/23/2026 1120552788 CMS
Axsome Therapeutics, Inc. $23.90 02/13/2024 Food and Beverage Undisputed 01/23/2026 1148353134 CMS
Axsome Therapeutics, Inc. $13.61 10/22/2024 Food and Beverage Undisputed 01/23/2026 1148353136 CMS
Corium, LLC $32.86 10/29/2024 Food and Beverage Undisputed 01/23/2026 1100204142 CMS
Indivior Inc. $24.55 01/30/2024 Food and Beverage Undisputed 01/23/2026 1144563003 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.14 02/29/2024 Food and Beverage Undisputed 01/23/2026 1143548404 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.03 04/23/2024 Food and Beverage Undisputed 01/23/2026 1143548408 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.55 05/02/2024 Food and Beverage Undisputed 01/23/2026 1143548413 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.15 05/07/2024 Education Undisputed 01/23/2026 1143548416 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.82 05/21/2024 Food and Beverage Undisputed 01/23/2026 1143548420 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.63 05/21/2024 Food and Beverage Undisputed 01/23/2026 1143548424 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.45 05/30/2024 Food and Beverage Undisputed 01/23/2026 1143548427 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.70 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143548431 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.48 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143548435 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.65 10/02/2024 Food and Beverage Undisputed 01/23/2026 1143548440 CMS
Lundbeck LLC $19.92 01/26/2024 Food and Beverage Undisputed 01/23/2026 1146060070 CMS
Lundbeck LLC $23.48 06/26/2024 Food and Beverage Undisputed 01/23/2026 1146060072 CMS
Lundbeck LLC $15.13 09/24/2024 Food and Beverage Undisputed 01/23/2026 1146060074 CMS
Lundbeck LLC $30.33 11/08/2024 Food and Beverage Undisputed 01/23/2026 1146060076 CMS
Neurocrine Biosciences, Inc. $25.51 02/27/2024 Food and Beverage Undisputed 01/23/2026 1150953196 CMS
Neurocrine Biosciences, Inc. $25.95 09/03/2024 Food and Beverage Undisputed 01/23/2026 1150951689 CMS
Neurocrine Biosciences, Inc. $16.43 10/17/2024 Food and Beverage Undisputed 01/23/2026 1150997661 CMS
Neurocrine Biosciences, Inc. $22.43 12/10/2024 Food and Beverage Undisputed 01/23/2026 1150967019 CMS
Otsuka America Pharmaceutical, Inc. $16.63 02/05/2024 Food and Beverage Undisputed 01/23/2026 1119136434 CMS
Otsuka America Pharmaceutical, Inc. $3.86 02/05/2024 Food and Beverage Undisputed 01/23/2026 1119136436 CMS
Otsuka America Pharmaceutical, Inc. $29.91 04/25/2024 Food and Beverage Undisputed 01/23/2026 1119136438 CMS
Otsuka America Pharmaceutical, Inc. $22.22 08/06/2024 Food and Beverage Undisputed 01/23/2026 1119136440 CMS
Otsuka America Pharmaceutical, Inc. $23.06 10/01/2024 Food and Beverage Undisputed 01/23/2026 1119136442 CMS
Otsuka America Pharmaceutical, Inc. $17.06 10/31/2024 Food and Beverage Undisputed 01/23/2026 1119136444 CMS
Otsuka America Pharmaceutical, Inc. $25.43 11/12/2024 Food and Beverage Undisputed 01/23/2026 1119136446 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.25 02/28/2024 Food and Beverage Undisputed 01/23/2026 1137791415 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.48 06/04/2024 Food and Beverage Undisputed 01/23/2026 1137791417 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.74 08/27/2024 Food and Beverage Undisputed 01/23/2026 1137791419 CMS
Teva Pharmaceuticals USA, Inc. $13.18 12/19/2024 Food and Beverage Undisputed 01/23/2026 1151461314 CMS
Vanda Pharmaceuticals Inc. $18.78 01/31/2024 Food and Beverage Undisputed 01/23/2026 1133957800 CMS
Vanda Pharmaceuticals Inc. $17.19 06/18/2024 Food and Beverage Undisputed 01/23/2026 1133957802 CMS
Vanda Pharmaceuticals Inc. $31.54 08/20/2024 Food and Beverage Undisputed 01/23/2026 1133957804 CMS
Vanda Pharmaceuticals Inc. $124.95 11/12/2024 Food and Beverage Undisputed 01/23/2026 1133957806 CMS
Vanda Pharmaceuticals Inc. $31.54 12/03/2024 Food and Beverage Undisputed 01/23/2026 1133957808 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.